US FDA’s Biologics Center Departures Grew Before More Than 100 RIFs Exited

 
• By Derrick Gingery
  
CBER and CDER seem to have lost a similar number of people to the RIF on a percentage basis. (Shutterstock)

More from US FDA

More from United States